PATH: Practical Alternative to Hospitalization

Sponsor
University of Pennsylvania (Other)
Overall Status
Completed
CT.gov ID
NCT04639102
Collaborator
Independence Blue Cross (Other)
72
1
2
4.7
15.3

Study Details

Study Description

Brief Summary

The investigators test the PATH program to evaluate whether the program allows patients to spend more days at home in comparison to patients who receive regular care. The program will involve patients from Penn Presbyterian Medical Center with a set of diagnoses and will provide patients with enhanced services upon discharge from the emergency department.

Condition or Disease Intervention/Treatment Phase
  • Other: PATH Intervention
N/A

Detailed Description

The PATH program seeks to provide patients with enhanced services upon discharge from the emergency department, including visiting home nurses, visiting home physical and occupational therapists, scheduled frequent telephone visits with a medical provider, care coordination to arrange outpatient evaluation and testing, social work services, and other services. The purpose of this study is to evaluate whether the PATH program allows patients to spend more days at home in comparison to patients who receive regular care.

The broad goal of this program is to provide patients with a personalized package of enhanced services following discharge from the emergency department. In some cases, patients enrolled in the PATH program are likely to be discharged home regardless of enrollment, but are deemed potentially high-risk for returning to the hospital due to their illness or other factors. In other cases, enrolled patients might otherwise have been hospitalized but decide with their clinician that recovery at home is possible with the increased supervision and care provided by PATH. For all patients, we seek to determine whether PATH is effective in expediting patient recovery from acute illness and reduce the time spent in hospital or nursing facilities.

Study Design

Study Type:
Interventional
Actual Enrollment :
72 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Other
Official Title:
Practical Alternative to Hospitalization
Actual Study Start Date :
Feb 9, 2021
Actual Primary Completion Date :
Jul 2, 2021
Actual Study Completion Date :
Jul 2, 2021

Arms and Interventions

Arm Intervention/Treatment
Experimental: PATH Intervention

Patients in the treatment arm will receive a personalized plan of care upon discharge from the emergency department.

Other: PATH Intervention
Patients will receive an enhanced level of care and service: Discharge planning- PATH clinicians will develop an individualized treatment plan at time of ED discharge. Each patient will receive next-day phone call to monitor status. There will be additional patient and family education, triage of new or worsening symptoms, and additional telephone contact as determined in treatment plan. There will be communication with home health teams as needed. Care coordination- PATH clinicians will arrange necessary primary medical doctor and specialty appointments. They will also communicate treatment plan to outpatient provider and arrange transportation for patients. Home monitoring/ Home Health Services- If patients are eligible and consent to home health services, they will be enrolled in Penn Medicine Home Health (PMHH). This will include virtual home monitoring, skilled nurse care, home physical and occupational therapists, social work services, and wound care.

No Intervention: Routine Care

Patients in the control arm will receive standard-of-care services (the care plan that the emergency physician would normally offer if PATH were not available) without PATH enrollment.

Outcome Measures

Primary Outcome Measures

  1. Days at home over 30 days [30 days]

    The number 30 minus the amount of days that patients spend in a hospital, nursing facility, or ED after discharge from the initial ED visit

  2. Days that patients are expired [30 days]

    The number of days that patients are expired

Secondary Outcome Measures

  1. Impact of PATH on hospital operations - Capture rate [5 months]

    Percentage of eligible patients enrolled into the program (capture rate)

  2. Quality of life at 30 days [5 months]

    This will be measured using the EQ-5D-5L questionnaire. This questionnaire measures quality of life on a 5-component scale including mobility, self-care, usual activities, pain/discomfort, and anxiety/depression. Each level is rated on scale that describes the degree of problems in that area.

  3. Functional status at 30 days [5 months]

    This will be measured using the Lawton and Brody Instrumental Activities of Daily Living (Lawton-Brody IADL) Scale. This instrument assesses independent living skills and functional ability with 8 questions, including behaviors like telephoning, shopping, food preparation, housekeeping, laundering, use of transportation, use of medicine, and financial behavior. The scale is scored dichotomously (0= less able, 1= more able). The higher the score, the greater the person's abilities. Women are scored on all 8 areas of function, but, for men, the areas of food preparation, housekeeping, laundering are excluded. A summary score ranges from 0 (low function, dependent) to 8 (high function, independent) for women, and 0 to 5 for men.

  4. Estimated cost (allowed charges) based on healthcare utilization [5 months]

    This will be determined by calculating allowed charges for healthcare services delivered to patient over 30-day follow up period.

  5. Impact of PATH on hospital operations - percentage of hospitalized patients [5 months]

    Measured by potential eligible hospitalizations (patients screened as eligible if more likely to have been hospitalized from the ED); actual avoided hospitalizations (patients more likely to have been hospitalized from the ED who are enrolled in either treatment or control arm); and actual avoided hospitalizations (patients more likely to have been hospitalized from the ED and enrolled in the treatment arm).

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Stable (Patients are deemed stable by ED clinician and PATH clinician per review of vital signs, history, exam, test results, and functional status)

  • Have active insurance

  • Domiciled at home (Patients must live in the community and not in nursing facility, shelter, or otherwise homeless)

  • Safe home environment

  • Live in Penn Medicine Home Health (PMHH) geographic catchment if enrolled in PMHH services

Exclusion Criteria:
  • Substance use disorder (No active untreated SUD, including alcohol, opioids, cocaine, or stimulants)

  • Serious mental health condition

  • Police custody

  • Homelessness

  • Anticipated procedures or surgeries

  • IV access (Patients with need for home infusion services or frequent blood testing after discharge must have standard level of IV access)

Contacts and Locations

Locations

Site City State Country Postal Code
1 University of Pennsylvania Philadelphia Pennsylvania United States 19104

Sponsors and Collaborators

  • University of Pennsylvania
  • Independence Blue Cross

Investigators

  • Principal Investigator: Austin Kilaru, MD, MSHP, University of Pennsylvania

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University of Pennsylvania
ClinicalTrials.gov Identifier:
NCT04639102
Other Study ID Numbers:
  • 844436
First Posted:
Nov 20, 2020
Last Update Posted:
Aug 10, 2022
Last Verified:
Aug 1, 2022
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Aug 10, 2022